scispace - formally typeset
Search or ask a question

What is the respective time period for completion of phase 1 of clinical trials studies? 

9 answers found

The steps required to develop and activate a clinical trial may require as much or more time than the actual completion of a trial.

Furthermore, phase 0 trials involving limited exposure of a study agent administered at low doses and/or for a short period allow them to be initiated under the Food and Drug Administration exploratory investigational new drug guidance with less preclinical toxicity data than usually required for traditional first-in-human studies.

Simulation studies can be incorporated into a clinical trial's planning phase to provide estimates for key accrual summaries including the mean and standard deviation of the accrual period. The accrual period of a clinical trial should be carefully considered, and the allocation of sufficient time for participant recruitment is a fundamental aspect of planning a clinical trial.

However, this is not the only piece of information that is useful for the design of phase II and phase III clinical trials.

These methods are useful for designing stratified phase II clinical trials.

The use of expansion cohorts in phase I trials was associated with success of subsequent phase II trials.

It is further reasoned that in acute phase clinical trials, unstructured modeling of time trends and within-subject error correlations may be preferred.

There also are long-lasting positive and negative impacts on those patients who choose to participate in phase 1 clinical trials.

This means that there is more flexibility available in the design and analysis of such studies than in phase III trials.